Norepinephrine–dopamine releasing agent
Source: Wikipedia, the free encyclopedia.
Further information: norepinephrine releasing agent and dopamine releasing agent
A norepinephrine–dopamine releasing agent (NDRA) is a type of
epinephrine) and dopamine
in the body and/or brain.
Examples of NDRAs include
4-methylaminorex, and benzylpiperazine
.
A closely related type of drug is a norepinephrine–dopamine reuptake inhibitor (NDRI).
See also
References
External links
Media related to Norepinephrine-dopamine releasing agents at Wikimedia Commons
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAAR1 |
| ||||||||||
| TAAR2 |
| ||||||||||
| TAAR5 |
| ||||||||||
† References for all endogenous human TAAR1 ligands are provided at List of trace amines
‡ References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.
| |||||||||||
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |